Loading...
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
CLN2 Batten disease (BD) is one of a broad class of lysosomal storage disorders that is characterized by the deficiency of lysosomal enzyme, TPP1, resulting in a build-up of toxic intracellular storage material in all organs and subsequent damage. A major challenge for BD therapeutics is delivery of...
Saved in:
| Published in: | Cells |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7290714/ https://ncbi.nlm.nih.gov/pubmed/32443895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9051273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|